ATON
Price
$5.53
Change
-$0.24 (-4.16%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
33.32M
CORT
Price
$83.92
Change
+$0.05 (+0.06%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
8.84B
29 days until earnings call
Interact to see
Advertisement

ATON vs CORT

Header iconATON vs CORT Comparison
Open Charts ATON vs CORTBanner chart's image
AlphaTON Capital
Price$5.53
Change-$0.24 (-4.16%)
Volume$315
Capitalization33.32M
Corcept Therapeutics
Price$83.92
Change+$0.05 (+0.06%)
Volume$3.93K
Capitalization8.84B
ATON vs CORT Comparison Chart in %
Loading...
ATON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATON vs. CORT commentary
Sep 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATON is a Hold and CORT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 30, 2025
Stock price -- (ATON: $5.53 vs. CORT: $83.90)
Brand notoriety: ATON and CORT are both not notable
ATON represents the Investment Managers, while CORT is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATON: 81% vs. CORT: 61%
Market capitalization -- ATON: $33.32M vs. CORT: $8.84B
ATON [@Investment Managers] is valued at $33.32M. CORT’s [@Biotechnology] market capitalization is $8.84B. The market cap for tickers in the [@Investment Managers] industry ranges from $179.08B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Investment Managers] industry is $7.37B. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATON’s FA Score shows that 0 FA rating(s) are green whileCORT’s FA Score has 1 green FA rating(s).

  • ATON’s FA Score: 0 green, 5 red.
  • CORT’s FA Score: 1 green, 4 red.
According to our system of comparison, CORT is a better buy in the long-term than ATON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATON’s TA Score shows that 5 TA indicator(s) are bullish while CORT’s TA Score has 5 bullish TA indicator(s).

  • ATON’s TA Score: 5 bullish, 5 bearish.
  • CORT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CORT is a better buy in the short-term than ATON.

Price Growth

ATON (@Investment Managers) experienced а -12.22% price change this week, while CORT (@Biotechnology) price change was +4.88% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was -1.67%. For the same industry, the average monthly price growth was +0.86%, and the average quarterly price growth was +23.97%.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.32%. For the same industry, the average monthly price growth was +11.43%, and the average quarterly price growth was +59.67%.

Reported Earning Dates

CORT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Investment Managers (-1.67% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

@Biotechnology (+2.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORT($8.84B) has a higher market cap than ATON($33.3M). CORT YTD gains are higher at: 66.442 vs. ATON (11.605). CORT has higher annual earnings (EBITDA): 104M vs. ATON (-6.74M). CORT has higher revenues than ATON: CORT (716M) vs ATON (0).
ATONCORTATON / CORT
Capitalization33.3M8.84B0%
EBITDA-6.74M104M-6%
Gain YTD11.60566.44217%
P/E RatioN/A74.91-
Revenue0716M-
Total CashN/A342M-
Total DebtN/A6.61M-
FUNDAMENTALS RATINGS
ATON vs CORT: Fundamental Ratings
ATON
CORT
OUTLOOK RATING
1..100
7639
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
10034
SMR RATING
1..100
10043
PRICE GROWTH RATING
1..100
6539
P/E GROWTH RATING
1..100
8610
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CORT's Valuation (83) in the Pharmaceuticals Other industry is in the same range as ATON (92) in the null industry. This means that CORT’s stock grew similarly to ATON’s over the last 12 months.

CORT's Profit vs Risk Rating (34) in the Pharmaceuticals Other industry is significantly better than the same rating for ATON (100) in the null industry. This means that CORT’s stock grew significantly faster than ATON’s over the last 12 months.

CORT's SMR Rating (43) in the Pharmaceuticals Other industry is somewhat better than the same rating for ATON (100) in the null industry. This means that CORT’s stock grew somewhat faster than ATON’s over the last 12 months.

CORT's Price Growth Rating (39) in the Pharmaceuticals Other industry is in the same range as ATON (65) in the null industry. This means that CORT’s stock grew similarly to ATON’s over the last 12 months.

CORT's P/E Growth Rating (10) in the Pharmaceuticals Other industry is significantly better than the same rating for ATON (86) in the null industry. This means that CORT’s stock grew significantly faster than ATON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATONCORT
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
70%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 21 days ago
86%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 15 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
70%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
ATON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGTX35.500.86
+2.48%
TG Therapeutics
HCSG16.36N/A
N/A
Healthcare Services Group
BN68.42-0.04
-0.06%
Brookfield Corp
OKUR2.51-0.03
-1.18%
OnKure Therapeutics Inc
HRZN6.14-0.08
-1.29%
Horizon Technology Finance Corp

ATON and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATON has been loosely correlated with AMGXF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ATON jumps, then AMGXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATON
1D Price
Change %
ATON100%
-7.68%
AMGXF - ATON
34%
Loosely correlated
N/A
NBY - ATON
34%
Loosely correlated
+2.34%
SPRB - ATON
30%
Poorly correlated
N/A
DYAI - ATON
29%
Poorly correlated
-5.98%
CORT - ATON
29%
Poorly correlated
+1.38%
More